ArticleBMC gastroenterology2023

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma.

Hai-Deng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.